Europe · Wires & real time · Reuters Business
Takeda launches sleep disorder pill in the US after DEA clearance removes final hurdle
Detailed summary
Takeda said on Thursday its narcolepsy pill, the first treatment to target the underlying cause of the rare sleep disorder, is now available in the US after a Drug Enforcement…
MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.reuters.com)
